Korean practice guidelines for gastric cancer 2022: an evidence-based, multidisciplinary approach

TH Kim, IH Kim, SJ Kang, M Choi, BH Kim… - Journal of gastric …, 2023 - pmc.ncbi.nlm.nih.gov
Gastric cancer is one of the most common cancers in Korea and the world. Since 2004, this
is the 4th gastric cancer guideline published in Korea which is the revised version of …

Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions

H Ji, C Hu, X Yang, Y Liu, G Ji, S Ge, X Wang… - … and Targeted Therapy, 2023 - nature.com
Lymph nodes (LNs) are important hubs for metastatic cell arrest and growth, immune
modulation, and secondary dissemination to distant sites through a series of mechanisms …

The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021

FH Wang, XT Zhang, YF Li, L Tang, XJ Qu… - Cancer …, 2021 - Wiley Online Library
There exist differences in the epidemiological characteristics, clinicopathological features,
tumor biological characteristics, treatment patterns, and drug selections between gastric …

Management of gastric cancer in Asia: resource-stratified guidelines

L Shen, YS Shan, HM Hu, TJ Price, B Sirohi… - The Lancet …, 2013 - thelancet.com
Gastric cancer is the fourth most common cancer globally, and is the second most common
cause of death from cancer worldwide. About three-quarters of newly diagnosed cases in …

Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node …

A Tsuburaya, J Mizusawa, Y Tanaka… - Journal of British …, 2014 - academic.oup.com
Background Locally advanced gastric cancer with extensive regional and/or para-aortic
lymph node (PAN) metastases is typically unresectable and associated with poor outcomes …

Changes in clinicopathological features and survival after gastrectomy for gastric cancer over a 20-year period

HS Ahn, HJ Lee, MW Yoo, SH Jeong… - Journal of British …, 2011 - academic.oup.com
Background The pattern of gastric cancer in the Western world is changing, with an
increased proportion of tumours in the upper stomach. The aim of this study was to …

The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2023

FH Wang, XT Zhang, L Tang, Q Wu… - Cancer …, 2024 - Wiley Online Library
The 2023 update of the Chinese Society of Clinical Oncology (CSCO) Clinical Guidelines for
Gastric Cancer focuses on standardizing cancer diagnosis and treatment in China, reflecting …

A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric …

S Ito, T Sano, J Mizusawa, D Takahari, H Katayama… - Gastric Cancer, 2017 - Springer
Background Gastric cancer with extensive lymph node metastasis is commonly considered
unresectable, with a poor prognosis. We previously reported the results of the use of …

Extended lymphadenectomy for gastric cancer in the neoadjuvant era: current status, clinical implications and contentious issues

L Marano, L Carbone, GE Poto, V Restaino… - Current …, 2023 - mdpi.com
Despite its decreasing incidence, gastric cancer remains an important global healthcare
problem due to its overall high prevalence and high mortality rate. Since the MAGIC and …

Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical …

M Terashima, Y Iwasaki, J Mizusawa, H Katayama… - Gastric Cancer, 2019 - Springer
Background The prognosis of patients with linitis plastica (type 4) and large (≥ 8 cm) ulcero-
invasive-type (type 3) gastric cancer is extremely poor, even after extended surgery and …